5/28/2013

A study of one hospital ICU found significantly higher treatment costs for patients with a central line-associated bloodstream infection than for those without, suggesting hospitals reap substantial profits from such complications, Johns Hopkins researchers reported in the American Journal of Medical Quality. Study researcher and hospital safety expert Dr. Peter Pronovost said hospitals that get windfall profits for treating outlier patients who develop complications have no incentive to implement quality improvement programs to prevent patient harm.

Related Summaries